These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16160010

  • 21. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
    Span LF, Dar SE, Shetty V, Mundle SD, Broady-Robinson L, Alvi S, Raymakers RA, de Witte T, Raza A.
    Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
    [Abstract] [Full Text] [Related]

  • 22. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
    Maschek H, Gutzmer R, Choritz H, Georgii A.
    Eur J Haematol; 1994 Nov; 53(5):280-7. PubMed ID: 7813708
    [Abstract] [Full Text] [Related]

  • 23. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
    Huh YO, Jilani I, Estey E, Giles F, Kantarjian H, Freireich E, Albitar M.
    Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Exacerbation of acute leukemia bearing isolated i(17q) along with proliferation of blasts with high BMI-1 expression].
    Mihara K, Kido M, Nakaju N, Fukumoto S, Matsumoto R, Takihara Y, Kimura A.
    Rinsho Ketsueki; 2007 Aug; 48(8):659-63. PubMed ID: 17867304
    [Abstract] [Full Text] [Related]

  • 26. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
    van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VH, Ossenkoppele GJ.
    Blood; 2008 Feb 01; 111(3):1067-77. PubMed ID: 17971483
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
    Dalamaga M, Karmaniolas K, Chamberland J, Nikolaidou A, Lekka A, Dionyssiou-Asteriou A, Mantzoros CS.
    Metabolism; 2013 Dec 01; 62(12):1830-9. PubMed ID: 24140093
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY, Chiu WF, Lee CT.
    Leukemia; 1991 Dec 01; 5(12):1092-8. PubMed ID: 1774958
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.
    Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O, Iwakiri R, Hayashi T, Sakamaki H, Murai Y, Tohyama K, Tomoyasu S, Nonaka Y, Mori M, Dan K, Yoshida Y.
    Blood; 2002 Dec 01; 100(12):3887-96. PubMed ID: 12393641
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hypoplastic myelodysplastic syndrome.
    Nand S, Godwin JE.
    Cancer; 1988 Sep 01; 62(5):958-64. PubMed ID: 3409176
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W.
    Leukemia; 1992 Jan 01; 6(1):52-9. PubMed ID: 1736014
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.